Some aspects of the management of bronchial asthma and chronic obstructive lung disease.
D000305:Adrenal Cortex Hormones / Q000009:adverse effects; D000318:Adrenergic beta-Agonists / Q000627:therapeutic use; D000628:Aminophylline / Q000627:therapeutic use; D001249:Asthma / Q000188:drug therapy* / Q000517:prevention & control; D001507:Beclomethasone / Q000627:therapeutic use; D001623:Betamethasone / Q000627:therapeutic use; D001993:Bronchodilator Agents / Q000627:therapeutic use; D002908:Chronic Disease; D004205:Cromolyn Sodium / Q000627:therapeutic use; D006801:Humans; D006854:Hydrocortisone / Q000008:administration & dosage / Q000627:therapeutic use; D008173:Lung Diseases, Obstructive / Q000188:drug therapy*; D011241:Prednisone / Q000008:administration & dosage / Q000627:therapeutic use
D000305:Adrenal Cortex Hormones; D000318:Adrenergic beta-Agonists; D001993:Bronchodilator Agents; D000628:Aminophylline; D001623:Betamethasone; D001507:Beclomethasone; D004205:Cromolyn Sodium; D011241:Prednisone; D006854:Hydrocortisone